ISTH Podcasts

Cancer-associated thrombosis remains one of the most complex and high-burden complications facing patients with cancer and the clinicians who care for them. Darko Antic, M.D., a leading hematologist from Serbia, discusses the real-world challenges of diagnosing and managing thrombosis in patients with cancer, particularly those with hematological malignancies. Together with host Julia Sandrin Gauer, Ph.D., they discuss the clinical impact of cancer-associated thrombosis, the hurdles clinicians face in everyday practice and how risk stratification tools such as the THROLY score can support clinical decision-making. Dr. Antic also shares insights from his frontline experience across diverse healthcare settings, including his leadership with the Serbian Lymphoma Group (SLG) and his role in advancing education through the SLG Podcast, offering a unique perspective on collaborative learning in hematology and oncology. Listen to the SLG podcast here: https://www.youtube.com/@SrpskaLimfomskaGrupa/videos

The countdown to the ISTH 2026 Congress is on and in this episode of the ISTH Pulse Podcast, we’re taking you behind the scenes of how one of the world’s leading scientific meetings comes together. Host Geoff Barnes is joined by Annual Congress Planning Committee leaders Marc Carrier and Françoise Dignat-George for an inside look at the planning and vision shaping this year’s program.

With more than 3,000 abstract submissions — the most in over a decade — the 2026 Congress reflects growing excitement across the thrombosis and hemostasis community. Tune in for a preview of the science, strategy and innovation driving ISTH 2026 and hear which sessions our guests are most excited about! Register for the Congress at www.isthcongress.org

Thrombotic thrombocytopenic purpura (TTP) is one of the most urgent diagnoses in hematology where every minute counts and laboratory data is critical. In this episode, experts Long Zheng and Ravi Sarode discuss the critical role of the laboratory in diagnosing and managing TTP, with a special focus on the complexities of ADAMTS13 testing. Together, they unpack the latest ISTH guideline updates, compare current testing approaches and share practical strategies to improve collaboration between clinicians and laboratory teams. Learn more at www.isth.org/page/ttpguidelines.

Artificial intelligence is rapidly reshaping medicine, but it’s about more than just algorithms. In this episode of the ISTH Pulse Podcast, host Geoff Barnes speaks with Suthesh Sivapalaratnam and Nick Gleadall about how AI and machine learning are being used to analyze large-scale datasets, identify disease earlier and support better patient care in thrombosis and hemostasis. They also discuss the launch of the ISTH Artificial Intelligence and Machine Learning Standing Committee, the innovative BloodCounts! Consortium, and how clinicians and researchers can begin exploring AI in their own work.

What does it take to turn fundamental science into meaningful advances in patient care? Today, we hear from Marie Hollenhorst, M.D., Ph.D., a physician-scientist working at the intersection of patient care and research. She discusses her early curiosity about blood science and shares some of the latest research from her lab in the U.S., including the 2024 ISTH Fundamental Research Career Development Award–funded project. Dr. Hollenhorst reflects on what the award has meant for her career, the importance of sustained investment in fundamental research and her experience mentoring an ISTH Training Fellow.

Patients with cancer face a significantly higher risk of venous thromboembolism (VTE), but despite decades of awareness, robust evidence for inpatient thromboprophylaxis in cancer patients is still lacking. Alok Khorana, M.D., an expert on cancer-associated thrombosis, joins the podcast to unpack this critical issue and discuss how we can improve thrombosis prevention and treatment for patients with cancer. Plus, Khorana shares important insights from his recent editorial published in Research and Practice in Thrombosis and Haemostasis (RPTH) on the public health impact of cancer-associated VTE: www.rpthjournal.org/article/S2475-0379(25)00623-5/fulltext

Our host sits down with the Lord Ajay Kakkar, M.D., Ph.D., Director of the Thrombosis Research Institute, as he reflects on his professional journey and the key moments that shaped his career, including his unique experiences working at the intersection of medicine and government with the U.K. Parliament. He also shares the profound influence of his late father, Vijay Kakkar, M.D., and how family legacy has informed his own approach to mentorship and governance. Tune in to this thoughtful conversation on science and service.

The Bleeding Disorders Research Collaborative (BDRC) is a groundbreaking initiative reshaping how bleeding disorders research is designed, conducted and prioritized. Joining the conversation are Michael Recht and Maria Santaella from the National Bleeding Disorders Foundation. Learn how the BDRC evolved from a national research blueprint, why patients are recognized as lived experience experts and how health equity is being intentionally built into research design and community partnerships. Learn more at www.bleeding.org/research/bleeding-disorders-research-collaborative.

Pulmonary embolism (PE) remains one of the most complex and high-stakes emergencies in medicine. In this episode of the ISTH Pulse Podcast, we’re joined by Stavros Konstantinides, M.D., to explore why gaps in PE treatment persist and how emerging evidence may help close them. Dr. Konstantinides breaks down the current landscape of PE management, the limitations of anticoagulation alone and the real-world impact of variability in care. Plus, listeners will hear results from STORM-PE randomized controlled trial, which could influence frontline clinical practice and patient access to advanced PE therapies. Please note that this episode is supported by Penumbra.

The countdown to the ISTH 2026 Congress in Paris has officially begun and we’re taking you behind the scenes of the planning process! In this episode, we sit down with members of the Congress leadership team to explore what makes the upcoming meeting truly special. Listen as our guests dive into what attendees can expect in Paris, including exciting updates to the scientific program, special sessions and themes designed to highlight innovation across thrombosis and hemostasis. With abstract submissions now open as of December 1, our guests also share valuable tips for researchers preparing their submissions, explain why contributing your science matters, and offer insights into what makes an abstract stand out in a highly competitive review process.

Whether you’re a seasoned ISTH attendee or planning your first Congress, this episode offers an inspiring look at everything happening on the road to Paris. Tune in and get ready for an unforgettable #ISTH2026. Learn more: www.isthcongress.org/